New York Oncology Hematology NY Onc Hem — Albany, New York

New York Oncology Hematology NY Onc Hem is a clinical research site located in Albany, New York, United States 12208.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology NY Onc Hem has participated in 1 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology NY Onc Hem?

New York Oncology Hematology NY Onc Hem has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology NY Onc Hem conducted?

New York Oncology Hematology NY Onc Hem has 1 clinical trials on record. Their work covers PI3K Pathway Activated Tumors.

Is New York Oncology Hematology NY Onc Hem accredited by Crixeo Health?

New York Oncology Hematology NY Onc Hem has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology NY Onc Hem?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.